Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

517.26
+3.670.71%
Post-market: 517.260.00000.00%19:38 EDT
Volume:160.79K
Turnover:83.04M
Market Cap:11.93B
PE:-37.90
High:520.89
Open:513.00
Low:507.06
Close:513.59
52wk High:615.00
52wk Low:265.00
Shares:23.06M
Float Shares:11.00M
Volume Ratio:0.58
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.6490
EPS(LYR):-12.8501
ROE:-49.35%
ROA:-17.62%
PB:21.94
PE(LYR):-40.25

Loading ...

Madrigal director Richard S. Levy disposes of USD 2.4 million common shares

Reuters
·
May 23

Madrigal Pharmaceuticals grants 5,308 inducement RSUs to 15 new employees

Reuters
·
May 22

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 22

Madrigal Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
May 13

Truist Raises Price Target on Madrigal Pharmaceuticals to $709 From $640, Keeps Buy Rating

MT Newswires Live
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings

Reuters
·
May 13

BUZZ-Truist raises PT on Madrigal Pharma on liver disease drug opportunity

Reuters
·
May 13

Truist Financial Sticks to Its Buy Rating for Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
May 13

A Look At Madrigal Pharmaceuticals (MDGL) Valuation After Rezdiffra Blockbuster Milestone And New MASH Pipeline Deals

Simply Wall St.
·
May 11

How Blockbuster Rezdiffra Sales and ARO‑PNPLA3 Licensing Will Impact Madrigal Pharmaceuticals (MDGL) Investors

Simply Wall St.
·
May 09

Madrigal Pharmaceuticals (MDGL) Receives a Buy from Barclays

TIPRANKS
·
May 08

Madrigal grants inducement equity awards to 47 new employees under 2025 plan

Reuters
·
May 08

Madrigal Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 07

Truist Financial Sticks to Its Buy Rating for Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
May 07

Madrigal Pharmaceuticals Inc : Clear Street Raises Target Price to $680 From $533

THOMSON REUTERS
·
May 07

Madrigal Pharmaceuticals reports Q1 EPS ($3.25), consensus ($4.14)

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL) and Pennant Group (PNTG)

TIPRANKS
·
May 07

BUZZ-Madrigal Pharma rises after Q1 revenue beat

Reuters
·
May 06

Stock Track | Madrigal Pharmaceuticals Soars 7.44% in Pre-market on Strong Q1 Earnings Beat and Pipeline Expansion

Stock Track
·
May 06

Madrigal Pharmaceuticals Price Target Maintained With a $620.00/Share by HC Wainwright & Co.

Dow Jones
·
May 06